Top Industry Leaders in the Hypertension Drugs Market
Pfizer partners with local distributors in Egypt and Morocco: July 2023, Pfizer announced partnerships with local distributors in Egypt and Morocco to improve access to its portfolio of antihypertensive medications, including Accuretic (lisinopril/ hydrochlorothiazide) and Zestril (lisinopril).
Novartis launches Sandoz Generics hypertension portfolio in Nigeria: June 2023, Novartis launched its Sandoz Generics portfolio of hypertension medications in Nigeria, offering affordable options for patients with limited access to branded drugs.
Sanofi expands access to Entresto (sacubitril/valsartan) in South Africa: May 2023, Sanofi secured expanded access to Entresto, a first-line treatment for heart failure with preserved ejection fraction (HFpEF), in South Africa through private insurance coverage.
List of Middle-East and Africa Hypertension Drugs Key Companies in the Market
- Abbott (US)
- Johnson & Johnson Services Inc. (US)
- Novartis (Switzerland)
- GlaxoSmithKline plc.(UK)
- AstraZeneca (UK)
- Bayer AG (Germany)
- Pfizer Inc.(US)
- Merck & Co. Inc. (US)
- Sanofi (France)
- Hoffmann-La Roche Ltd (Switzerland)
- Gilead (US)